Artículos de revistas
Fat-specific Dicer Deficiency Accelerates Aging And Mitigates Several Effects Of Dietary Restriction In Mice
Registro en:
Aging-us. Impact Journals Llc, v. 8, p. 1201 - 1222, 2016.
1945-4589
WOS:000380177700007
10.18632/aging.100970
Autor
Reis
Felipe C. G.; Branquinho
Jessica L. O.; Brandao
Bruna B.; Guerra
Beatriz A.; Silva
Ismael D.; Frontini
Andrea; Thomou
Thomas; Sartini
Loris; Cinti
Saverio; Kahn
C. Ronald; Festuccia
William T.; Kowaltowski
Alicia J.; Mori
Marcelo A.
Institución
Resumen
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Aging increases the risk of type 2 diabetes, and this can be prevented by dietary restriction (DR). We have previously shown that DR inhibits the downregulation of miRNAs and their processing enzymes - mainly Dicer - that occurs with aging in mouse white adipose tissue (WAT). Here we used fat-specific Dicer knockout mice (AdicerKO) to understand the contributions of adipose tissue Dicer to the metabolic effects of aging and DR. Metabolomic data uncovered a clear distinction between the serum metabolite profiles of Lox control and AdicerKO mice, with a notable elevation of branched-chain amino acids (BCAA) in AdicerKO. These profiles were associated with reduced oxidative metabolism and increased lactate in WAT of AdicerKO mice and were accompanied by structural and functional changes in mitochondria, particularly under DR. AdicerKO mice displayed increased mTORC1 activation in WAT and skeletal muscle, where Dicer expression is not affected. This was accompanied by accelerated age-associated insulin resistance and premature mortality. Moreover, DR-induced insulin sensitivity was abrogated in AdicerKO mice. This was reverted by rapamycin injection, demonstrating that insulin resistance in AdicerKO mice is caused by mTORC1 hyperactivation. Our study evidences a DR-modulated role for WAT Dicer in controlling metabolism and insulin resistance. 8 6 1201 1222 FAPESP [2010/52557-0, 2015/01316-7, 2011/24109-6] CNPq CAPES Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)